9/17/2018 12:29:59 PM - Pulled back from its all-time high as a volume-driven loss last week violated its 50 DMA line ($297) and undercut prior lows. Noted in prior mid-day reports - <i>&quot;Reported earnings +250% on +9% sales revenues for the Jun &#39;18 quarter, its 3rd consecutive quarterly earnings comparison above the +25% minimum guideline (C criteria). Annual earnings growth has been strong (A criteria) since a downturn in FY &#39;14.&quot;</i><br><hr>9/14/2018 12:36:10 PM - Pulled back from its all-time high as a volume-driven loss violated its 50 DMA line ($297) on the prior session. Noted in prior mid-day reports - <i>&quot;Reported earnings +250% on +9% sales revenues for the Jun &#39;18 quarter, its 3rd consecutive quarterly earnings comparison above the +25% minimum guideline (C criteria). Annual earnings growth has been strong (A criteria) since a downturn in FY &#39;14.&quot;</i><br><hr>9/13/2018 12:58:45 PM - Pulling back from its all-time high with today&#39;s volume-driven loss violating its 50 DMA line ($297). Last noted with caution in the 9/11/18 mid-day report - <i>&quot;Reported earnings +250% on +9% sales revenues for the Jun &#39;18 quarter, its 3rd consecutive quarterly earnings comparison above the +25% minimum guideline (C criteria). Annual earnings growth has been strong (A criteria) since a downturn in FY &#39;14.&quot;</i><br><hr>9/11/2018 12:16:43 PM - Perched near its all-time high, consolidating near its 50 DMA line ($297). Reported earnings +250% on +9% sales revenues for the Jun &#39;18 quarter, its 3rd consecutive quarterly earnings comparison above the +25% minimum guideline (C criteria). Annual earnings growth has been strong (A criteria) since a downturn in FY &#39;14.<br><hr>8/14/2018 2:08:17 PM - Perched near its all-time high, consolidating near its 50 DMA line. Reported earnings +250% on +9% sales revenues for the Jun &#39;18 quarter, its 3rd consecutive quarterly earnings comparison above the +25% minimum guideline (C criteria). Annual earnings growth has been strong (A criteria) since a downturn in FY &#39;14.<br><hr>8/10/2018 1:05:51 PM - Gapped up today hitting a new all-time high but promptly reversed into the red. Reported earnings +250% on +9% sales revenues for the Jun &#39;18 quarter, its 3rd consecutive quarterly earnings comparison above the +25% minimum guideline (C criteria). Annual earnings growth has been strong (A criteria) since a downturn in FY &#39;14.<br><hr>5/10/2018 12:54:18 PM - Gapped up today hitting a new all-time high, rising from a &quot;late stage&quot; base. Reported earnings +35% on +50% sales revenues for the Mar &#39;18 quarter. Fundamental concerns remain because its prior quarterly earnings (C criteria) included lower results for the Jun and Sep &#39;17 versus the year ago periods. Annual earnings growth has been strong (A criteria) since a downturn in FY &#39;14.<br><hr>3/2/2018 12:24:46 PM - Gapped up today hitting a new all-time high. Reported strong Dec &#39;17 quarterly results. Fundamental concerns remain because its prior quarterly and annual earnings (C and A criteria) history has been up and down.<br><hr>8/10/2017 12:26:27 PM - Pulling back below its 50 DMA line today. Reported earnings -34% on +243% sales revenues for the Jun &#39;17 quarter. Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds fell from 455 in Dec &#39;16 to 412 in Jun &#39;17, however its current Up/Down Volume Ratio of 1.2 is a reassuring sign its shares have been under slight accumulation over the past 50 days (I criteria).<br><hr>7/11/2017 12:20:09 PM - Wedged to a new all-time high with recent gains lacking great volume conviction. Reported earnings +33% on +176% sales revenues for the Mar &#39;17 quarter. Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds fell from 455 in Dec &#39;16 to 416 in Jun &#39;17, however its current Up/Down Volume Ratio of 1.3 is a reassuring sign its shares have been under accumulation over the past 50 days (I criteria).<br><hr>7/7/2017 12:28:17 PM - Wedged to a new all-time high with recent gains lacking great volume conviction. Reported earnings +33% on +176% sales revenues for the Mar &#39;17 quarter. Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds fell from 455 in Dec &#39;16 to 414 in Jun &#39;17, however its current Up/Down Volume Ratio of 1.5 is a reassuring sign concerning the I criteria.<br><hr>7/6/2017 12:10:12 PM - Wedged to a new all-time high with recent gains lacking great volume conviction. Reported earnings +33% on +176% sales revenues for the Mar &#39;17 quarter. Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds fell from 455 in Dec &#39;16 to 415 in Jun &#39;17, however its current Up/Down Volume Ratio of 1.6 is a reassuring sign concerning the I criteria.<br><hr>5/11/2017 12:57:39 PM - Rallied to new 52-week and all-time highs with today&#39;s volume-driven gain. Reported earnings +33% on +176% sales revenues for the Mar &#39;17 quarter. Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 440 in Mar &#39;17, a reassuring sign concerning the I criteria.<br><hr>3/2/2017 12:07:51 PM - Gapped down today. Reported earnings +25% on +6% sales revenues for the Dec &#39;16 quarter and fundamental concerns remain. The 10/25/16 mid-day report last cautioned - <i>&quot;Gapped up and rallied to new 52-week highs with recent news of an agreement under which ICU Medical will acquire all of Pfizer&#39;s global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Earnings rose +19% on +15% sales revenues for the Jun &#39;16 quarter, below the +25% minimum guideline (C criteria). Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 409 in Jun &#39;16, a reassuring sign concerning the I criteria.&quot;</i><br><hr>10/25/2016 12:23:32 PM - The 10/10/16 mid-day report cautioned - <i>&quot;Gapped up and rallied to new 52-week highs with recent news of an agreement under which ICU Medical will acquire all of Pfizer&#39;s global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Earnings rose +19% on +15% sales revenues for the Jun &#39;16 quarter, below the +25% minimum guideline (C criteria). Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 409 in Jun &#39;16, a reassuring sign concerning the I criteria.&quot;</i><br><hr>10/10/2016 12:20:42 PM - Gapped up and rallied to new 52-week highs with recent news of an agreement under which ICU Medical will acquire all of Pfizer&#39;s global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Earnings rose +19% on +15% sales revenues for the Jun &#39;16 quarter, below the +25% minimum guideline (C criteria). Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 409 in Jun &#39;16, a reassuring sign concerning the I criteria.<br><hr>10/7/2016 12:23:54 PM - Gapped up and rallied to new 52-week highs this week on news of an agreement under which ICU Medical will acquire all of Pfizer&#39;s global infusion therapy business, Hospira Infusion Systems, for $1 billion in cash and stock. Earnings rose +19% on +15% sales revenues for the Jun &#39;16 quarter, below the +25% minimum guideline (C criteria). Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 409 in Jun &#39;16, a reassuring sign concerning the I criteria.<br><hr>11/18/2015 12:34:26 PM - Found support at the 50 DMA line while consolidating since last noted 11/06/15 when it gapped up and challenged its 52-week high.  Earnings rose +52% on +11% sales revenues for the Sep &#39;15 quarter, its 3rd consecutive quarterly comparison with earnings above the +25% minimum guideline. Fundamental concerns remain because its annual earnings (A criteria) history has been up and down. Sub par sales revenues growth also is not a match with the guidelines of the fact-based investment system. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 379 in Jun &#39;15, a reassuring sign concerning the I criteria.<br><hr>11/6/2015 12:25:44 PM - Gapped up today for a new 52-week high.  Earnings rose +52% on +11% sales revenues for the Sep &#39;15 quarter. Fundamental concerns remain and prior mid-day reports cautioned - <em>&quot;Prior quarterly and annual earnings (C and A criteria) and its sales revenues history is not a match with the minimum guidelines of the fact-based investment system. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 355 in Jun &#39;15, a reassuring sign concerning the I criteria.&quot;</em><br><hr>11/3/2015 12:37:16 PM - Consolidating near its 50 DMA line. Earnings rose +90% on +6% sales revenues for the Jun &#39;15 quarter. Sputtering since last noted with caution in the 8/18/15 mid-day report with caution - <em>&quot;Prior quarterly and annual earnings (C and A criteria) and its sales revenues history is not a match with the minimum guidelines of the fact-based investment system. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 355 in Jun &#39;15, a reassuring sign concerning the I criteria.&quot;</em><br><hr>8/18/2015 12:34:36 PM - Holding its ground stubbornly and inching higher since its gap up on 8/11/15 for new 52-weeks. Earnings rose +90% on +6% sales revenues for the Jun &#39;15 quarter. Prior mid-day reports cautioned members - <em>&quot;Prior quarterly and annual earnings (C and A criteria) and its sales revenues history is not a match with the minimum guidelines of the fact-based investment system. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 355 in Jun &#39;15, a reassuring sign concerning the I criteria.&quot;</em><br><hr>8/13/2015 12:50:37 PM - Gapped up on 8/11/15 hitting a new 52-week high following news earnings rose +90% on +6% sales revenues for the Jun &#39;15 quarter. Prior  mid-day reports cautioned members - <em>&quot;Prior quarterly and annual earnings (C and A criteria) and its sales revenues history is not a match with the minimum guidelines of the fact-based investment system. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 355 in Jun &#39;15, a reassuring sign concerning the I criteria.&quot;</em><br><hr>8/12/2015 12:49:02 PM - Gapped up on the prior session hitting a new 52-week high following news earnings rose +90% on +6% sales revenues for the Jun &#39;15 quarter. The 8/11/15 mid-day report cautioned members - <em>&quot;Prior quarterly and annual earnings (C and A criteria) and its sales revenues history is not a match with the minimum guidelines of the fact-based investment system. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 355 in Jun &#39;15, a reassuring sign concerning the I criteria.&quot;</em><br><hr>8/11/2015 12:56:29 PM - Gapped up today hitting a new 52-week high following news earnings rose +90% on +6% sales revenues for the Jun &#39;15 quarter. Prior quarterly and annual earnings (C and A criteria) and its sales revenues history is not a match with the minimum guidelines of the fact-based investment system. Ownership by top-rated funds rose from 296 in Sep &#39;14 to 355 in Jun &#39;15, a reassuring sign concerning the I criteria.<br><hr>6/14/2013 12:19:32 PM - Perched at its 52-week high following a spurt of volume-driven gains.  Quarterly earnings (<strong>C</strong> criteria) and sales revenues increases through Mar &#39;13 are not a match with the minimum guidelines of the fact-based investment system. Ownership by top-rated funds rose from <strong>279</strong> in Jun &#39;12 to <strong>310</strong> in Mar &#39;13, a reassuring sign concerning the <strong>I</strong> criteria.<br><hr>10/16/2012 12:32:47 PM - Perched within close striking distance of its 52-week high today. Quarterly earnings increased <strong>+26%</strong> on <strong>+6%</strong> sales in the Sep &#39;12 quarter following a streak of <strong>5</strong> comparisons with sub par earnings below the <strong>+25%</strong> minimum guideline (<strong>C</strong> criteria). Ownership by top-rated funds rose from <strong>265</strong> in Dec &#39;11 to <strong>296</strong> in Sep &#39;12 a reassuring sign concerning the I criteria.<br><hr>7/15/2011 1:08:46 PM - No resistance remains due to overhead supply. It gapped up on the prior session hitting a new 52-week high, rising from an orderly base with triple its average daily volume total. Quarterly earnings increases have been above the <strong>+25%</strong> guideline in the past <strong>4</strong> comparisons through Mar &#39;11 versus the year ago period. Its annual earnings (<strong>A</strong> criteria) history has been slow and steady in recent years, and Street estimates call for growth in the <strong>+9-10%</strong> range for FY &#39;11 and FY &#39;12. Ownership by top-rated funds has been nearly unchanged in the past year.  It survived by failed to impress since last noted in the 7/09/09 mid-day report.<br><hr>7/9/2009 12:47:54 PM - Gain on higher volume today, hitting another new 52 week high. Recent quarterly earnings have improved, but its up and down annual earnings history raises fundamental concerns with respect to the investment system&#39;s <strong>A</strong> criteria. Street estimates for FY &#39;09 earnings only are calling for a <strong>+9%</strong> increase.<br><hr>6/19/2009 1:27:01 PM - Gain  on higher volume today after a small gap up, hitting another  new 52 week high. Recent quarterly earnings have improved, but its up and down annual earnings history raises fundamental concerns with respect to the investment system&#39;s <strong>A</strong> criteria.<br><hr>6/18/2009 2:49:02 PM - Gaining ground today for a new 52 week high. Recent quarterly earnings have improved, but its up and down annual earnings history raises fundamental concerns with respect to the investment system&#39;s <strong>A</strong> criteria.<br><hr>4/29/2009 12:04:56 PM - Gaining ground today  for a new 52 week high, while additional overhead supply may still act as resistance.    It stubbornly held its ground since  a considerable gap up gain on 4/17/09 following better than expected earnings news.   Recent quarterly earnings have improved, but its up and down annual earnings history  raises fundamental concerns with respect to the investment system&#39;s  <strong>A</strong> criteria.<br><hr>4/20/2009 11:20:57 AM - Early gains today had it trading within <strong>8</strong> cents of a new 52 week high, attracting interest after a considerable gap up gain on 4/17/09  following  better than expected earnings news. Its considerable gain with high volume has it approaching its 52-week high, however additional overhead supply is a concern. Recent quarterly earnings have improved, but its up and down annual earnings history (the <strong>A</strong> criteria) is below guidelines.<br><hr>4/17/2009 11:21:08 AM - Gapped up today after reporting better than expected earnings. Its considerable gain with high volume has it approaching its  52-week high, however additional overhead supply is a concern. Recent quarterly earnings have improved, but its up and down annual earnings history (the <strong>A</strong> criteria) is below guidelines.<br><hr>2/26/2009 1:22:15 PM - Now consolidating above its 50 DMA line and earlier highs, it promptly reversed after reaching a new 52-week high, a sign of distributional pressure. Solid gains on 2/11 &amp; 2/12 backed by above average volume helped it break out from an orderly flat base. Quarterly and annual earnings history is below guidelines, leaving fundamental concerns.<br><hr>2/25/2009 12:08:05 PM - Consolidating above  its 50 DMA line and earlier highs, it promptly reversed after reaching a new 52-week high, a sign of  distributional pressure.    Solid gains on 2/11 &amp; 2/12 backed by above average volume helped it break out from an orderly flat base. Quarterly and annual earnings history is below guidelines, leaving fundamental concerns.<br><hr>2/24/2009 12:42:04 PM - Today it isB falling back into its prior base and near its 50 DMA line. Encountering distributional pressure after recently reaching a new 52-week high.B Solid gains on 2/11 &amp; 2/12 backed by above average volume helped it break out from an orderly flat base. Quarterly and annual earnings history is below guidelines, leaving fundamental concerns.<br><hr>2/20/2009 12:37:00 PM - Hit another new 52-week high today, following through after  solid gains on 2/11 &amp; 2/12 backed by above average volume helped it break  out from an orderly flat base. Quarterly and annual earnings history is below guidelines, leaving fundamental concerns.<br><hr>2/19/2009 12:36:56 PM - Hit a new 52-week high today with a solid gain backed by above average volume.   It  broke out  from an orderly flat base last week with <strong>2</strong> consecutive gains backed by above average volume. Quarterly and annual earnings history is below guidelines, leaving fundamental concerns.<br><hr>2/17/2009 12:36:34 PM - Consolidating near its 52-week high after rising from an orderly flat base last week with <strong>2</strong> consecutive gains backed by above average volume. Quarterly and annual earnings history is below guidelines.<br><hr>2/13/2009 12:56:39 PM - Consolidating near its 52-week high after rising from an orderly flat base with <strong>2</strong> consecutive gains  backed by  above average volume. Quarterly and annual earnings history is below guidelines.<br><hr>2/12/2009 1:09:49 PM - Rising from an orderly flat base with gains yesterday and today with volume above average.  Quarterly and annual earnings history is  below guidelines.<br><hr>2/9/2009 12:27:58 PM - Lackluster quarterly and annual earnings history, below guidelines.<br><hr>2/5/2009 12:36:54 PM - Lackluster quarterly and annual earnings history, below guidelines.<br><hr>